113-O12B-Lipid Nanoparticles (Targeted to Lymph Nodes) |
CDCLP24-013-L |
113-O12B/Chol/DOPE/DMG-PEG (16:4.8:3:2.4, mole ratio) |
|
INQUIRY
|
4N4T-Lipid Nanoparticles |
CDCLP24-005-L |
4N4T lipids/DOPE/Chol/DMG-PEG2K (35:16:46.5:2.5, mole ratio) |
|
INQUIRY
|
AA3-DLin-Lipid Nanoparticles |
CDCLP24-011-L |
AA3-DLin/DOPE/Cholesterol/DMG-PEG (40:40:25:0.5, molar ratio) |
|
INQUIRY
|
AMB-POC18-Lipid Nanoparticles (Targeted to Spleen) |
CDCLP24-012-L |
AMB-POC8/DOPE/OMG-PEG (50:20:0.5, mole ratio) |
|
INQUIRY
|
C10-Lipid Nanoparticles (Targeted to Liver) |
CDCLP24-008-L |
Ionizable lipid/DOPE/Cholesterol/PEG-lipid (26.5:20:52:1.5, mole ratio) |
|
INQUIRY
|
C5-Lipid Nanoparticles (Targeted to Placenta) |
CDCLP24-006-L |
C12-494/DOPE/Chol/Lipid-PEG2K (51.4:14:32.7:1.9, mole ratio) |
|
INQUIRY
|
DB-Lipid Nanoparticles |
CDCLP24-004-L |
DB-lipidoids(11-10-8)/DOPE/Cholesterol/DMG-PEG (40:10:48.8:1.5, mole ratio) |
|
INQUIRY
|
FA-Lipid Nanoparticles (Targeted to Macrophages) |
CDCLP24-001-L |
DOTAP/Cholesterol/DSPC/DSPE-PEG2000 (50:38.5:10:1.5, mole ratio) |
|
INQUIRY
|
FPD-Lipid Nanoparticles |
CDCLP24-003-L |
SM-102/DSPC/cholesterol/FPD (50:10:38.5:1.5, mole ratio) |
|
INQUIRY
|
M-MC3-Lipid Nanoparticles (Targeted to Liver Macrophages) |
CDCLP24-014-L |
DLin-MC3-DMA/DSPC/Cholesterol/DMG-PEG/Man-DSPE-PEG (50:10:38.5:0.5:1.0, mole ratio) |
|
INQUIRY
|
Sito-Lipid Nanoparticles |
CDCLP24-007-L |
DLin-MC3-DMA/β-sitosterol/DMG-PEG2K/DSPC (50:36.5:3.5:10, mole ratio) |
|
INQUIRY
|
Temperature responsive-Lipid Nanoparticles #1 |
CDCLP24-009-L |
DPPC:MSPC:DSPE-PEG2000 (86.5:9.7:3.8, mol %) |
|
INQUIRY
|
Temperature responsive-Lipid Nanoparticles #2 |
CDCLP24-010-L |
DPPC:MSPC:DSPE-PEG2000 (21.6:2.6:1.0, mole ratio) |
|
INQUIRY
|
W-Lipid Nanoparticles (Targeted to Chondrocytes) |
CDCLP24-002-L |
DOTAP/Cholesterol/DSPC/DSPE-PEG2000 (50:38.5:10:1.5, mole ratio) |
|
INQUIRY
|